ENDOTOXIN AND TUMOR-NECROSIS-FACTOR DO NOT CAUSE MORTALITY FROM CECAL LIGATION AND PUNCTURE

被引:32
作者
MCMASTERS, KM
PEYTON, JC
HADJIMINAS, DJ
CHEADLE, WG
机构
[1] UNIV LOUISVILLE,SCH MED,DEPT SURG,LOUISVILLE,KY 40292
[2] VET ADM MED CTR,LOUISVILLE,KY 40202
关键词
CLASS II MHC ANTIGENS; ENDOTOXIN; INTERLEUKIN; 1; SEPSIS; TUMOR NECROSIS FACTOR;
D O I
10.1016/1043-4666(94)90081-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophage tumour necrosis factor-alpha (TNF-alpha) production is thought to represent an important pathogenic mechanism by which Gram-negative sepsis is mediated. We compared the effects of caecal ligation and puncture (CLP) on endotoxin-sensitive (C3H/HeSnJ) and endotoxin-resistant (C3H/HeJ) mice. Mortality after CLP for C3H/HeSnJ mice compared with C3H/HeJ mice was not significantly different (32% and 55%, respectively). When survivors were injected with lipopolysaccharide intraperitoneally on the 7th day after CLP, the mortality rate was 82% for C3H/HeSnJ mice versus 0% for C3H/HeJ mice (P < 0.0001). Serum endotoxin levels at 24 h after CLP were only slightly elevated. Serum TNF levels and peritoneal macrophage TNF production were undetectable in C3H/HeJ mice and were only slightly elevated in C3H/HeSnJ mice by 24 h after CLP. Peritoneal macrophage mRNA levels for TNF-alpha, IL-1 beta, and I-A alpha displayed a similar pattern in the two strains of mice, with a 2- to 3-fold increase in TNF-alpha and IL-1 beta mRNA levels by 24 h and a sharp decrease in I-A alpha mRNA by 24 h. The cause of mortality in mice that undergo CLP cannot be attributed to overwhelming endotoxemia and/or TNF production.
引用
收藏
页码:530 / 536
页数:7
相关论文
共 50 条
[21]   THE COMPLEX PATTERN OF CYTOKINES IN SEPSIS - ASSOCIATION BETWEEN PROSTAGLANDINS, CACHECTIN, AND INTERLEUKINS [J].
ERTEL, W ;
MORRISON, MH ;
WANG, P ;
BA, ZF ;
AYALA, A ;
CHAUDRY, IH .
ANNALS OF SURGERY, 1991, 214 (02) :141-148
[22]   WEHI-164 SUBCLONE-13 ASSAY FOR TNF - SENSITIVITY, SPECIFICITY, AND RELIABILITY [J].
ESKANDARI, MK ;
NGUYEN, DT ;
KUNKEL, SL ;
REMICK, DG .
IMMUNOLOGICAL INVESTIGATIONS, 1990, 19 (01) :69-79
[23]  
ESKANDARI MK, 1992, J IMMUNOL, V148, P2724
[24]  
EVANS GF, 1989, CIRC SHOCK, V29, P279
[25]  
EVANS TJ, 1993, J IMMUNOL, V150, P5033
[26]   TOLERANCE TO TUMOR NECROSIS FACTOR IN RATS AND THE RELATIONSHIP TO ENDOTOXIN TOLERANCE AND TOXICITY [J].
FRAKER, DL ;
STOVROFF, MC ;
MERINO, MJ ;
NORTON, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (01) :95-105
[27]   ALTERATION OF MONONUCLEAR CELL IMMUNE-ASSOCIATED ANTIGEN EXPRESSION, INTERLEUKIN-1 EXPRESSION, AND ANTIGEN PRESENTATION DURING INTRAABDOMINAL INFECTION [J].
GALLINARO, RN ;
NAZIRI, W ;
MCMASTERS, KM ;
PEYTON, JC ;
CHEADLE, WG .
SHOCK, 1994, 1 (02) :130-134
[28]   INTERLEUKIN-1 RECEPTOR ANTAGONIST ACTIVITY OF A HUMAN INTERLEUKIN-1 INHIBITOR [J].
HANNUM, CH ;
WILCOX, CJ ;
AREND, WP ;
JOSLIN, FG ;
DRIPPS, DJ ;
HEIMDAL, PL ;
ARMES, LG ;
SOMMER, A ;
EISENBERG, SP ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :336-340
[29]   MODULATION OF INFECTION BY GAMMA-INTERFERON TREATMENT FOLLOWING TRAUMA [J].
HERSHMAN, MJ ;
POLK, HC ;
PIETSCH, JD ;
SHIELDS, RE ;
WELLHAUSEN, SR ;
SONNENFELD, G .
INFECTION AND IMMUNITY, 1988, 56 (09) :2412-2416
[30]   MONOCYTE HLA-DR ANTIGEN EXPRESSION CHARACTERIZES CLINICAL OUTCOME IN THE TRAUMA PATIENT [J].
HERSHMAN, MJ ;
CHEADLE, WG ;
WELLHAUSEN, SR ;
DAVIDSON, PF ;
POLK, HC .
BRITISH JOURNAL OF SURGERY, 1990, 77 (02) :204-207